首页> 美国卫生研究院文献>Cell Transplantation >Immunological Characteristics and Properties of Glial Restricted Progenitorsof Mice Canine Primary Culture Suspensions and Human QSV40 Immortalized Cell Lines forProspective Therapies of Neurodegenerative Disorders
【2h】

Immunological Characteristics and Properties of Glial Restricted Progenitorsof Mice Canine Primary Culture Suspensions and Human QSV40 Immortalized Cell Lines forProspective Therapies of Neurodegenerative Disorders

机译:胶质细胞限制性祖细胞的免疫学特性和特性小鼠犬原代培养悬浮液和人类QSV40永生化细胞系的制备神经退行性疾病的前瞻性疗法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Neurodegeneration can be defined as a process in which neuronal structures and functions undergo changes leading to reduced neuronal survival and increased cell death in the central nervous system (CNS). Neuronal degeneration in specific regions of the CNS is a hallmark of many neurodegenerative disorders, and there is reliable proof that neural stem cells bring therapeutic benefits in treatment of neurological lesions. However, effective therapy with neural stem cells is associated with their biological properties. The assessment of immunological properties and comprehensive studies on the biology of glial restricted progenitors (GRP) are necessary prior to the application of these cells in humans. This study provides an in vitro characterization of the QSV40 glial human cell line, as well as murine and canine primary culture suspensions of GRPs and their mature, astrocytic forms using flow cytometry and immunohistochemical staining. Cytokines and chemokines released by GRPs were assessed by Multiplex ELISA. Some immunological differences observed among species suggest the necessity of reconsidering the pre-clinical model, and that careful testing of immunomodulatory strategies is required before cell transplantation into the CNS can be undertaken.
机译:神经退行性变可以定义为其中神经元结构和功能发生变化从而导致神经元存活减少和中枢神经系统(CNS)细胞死亡增加的过程。中枢神经系统特定区域的神经元变性是许多神经退行性疾病的标志,并且有可靠的证据表明神经干细胞在神经损伤的治疗中具有治疗作用。但是,神经干细胞的有效治疗与其生物学特性有关。在将这些细胞应用于人类之前,必须进行免疫学性质评估以及对神经胶质细胞限制性祖细胞(GRP)进行全面研究。这项研究使用流式细胞仪和免疫组化染色技术对QSV40胶质人类细胞系以及GRP的鼠类和犬类原代培养悬浮液及其成熟的星形细胞形式进行了体外表征。通过多重ELISA评估由GRP释放的细胞因子和趋化因子。在物种间观察到的一些免疫学差异表明,有必要重新考虑临床前模型,并且在将细胞移植到中枢神经系统之前,需要仔细测试免疫调节策略。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号